Radiotherapy in the adjuvant setting of cervical carcinoma: Treatment, results, and prognostic factors

International Journal of Gynecological Cancer

Volumn 17, Issue 4, 2007, Pages 813-820

  Atahan, I L ^a   Yildiz, F ^a   Ozyar, E ^a   Pehlivan, B ^a   Genc, M ^b   Kose, M F ^c   Tulunay, G ^c   Ayhan, A ^a   Yuce, K ^a   Guler, N ^a   Kucukali, T ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c Etlik Maternity and Women's Health Teaching Hospital   (Turkey)

Author keywords

Cervical cancer; Prognostic factors; Radiotherapy

Indexed keywords

CISPLATIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIUM; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RISK FACTOR; STROMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA; VAGINA;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 34447311412     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00887.x     Document Type: Article

References (41)

1. Perez CA, Kavanagh BD. Gynecologic tumors: uterine cervix. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, eds. Principles and practice of radiation oncology, 4th edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2004: 1800 915.
2. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. Am J Obstet Gynecol 1975 123: 535 42.
3. Roddick JW, Greenlaw RH. Treatment of cervical cancer. Am J Obstet Gynecol 1971 19: 754 64.
4. Landoni F, Maneo A, Colombo A et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997 350: 535 40.
5. Rotman M, Sedlis A, Piedmonte MR et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2006 65: 169 76.
6. Bianchi UA, Sartori E, Pecorelli S et al. Treatment of primary invasive cervical cancer: considerations on 997 consecutive cases. Eur J Gynecol Oncol 1988 9: 47 53.
7. Mitsuhashi N, Takahashi M, Yamakawa M et al. Results of postoperative radiation therapy for patients with carcinoma of the uterine cervix: evaluation of intravaginal cone boost with an electron beam. Gynecol Oncol 1995 57: 321 6.
8. Kinney WK, Hodge DO, Egorshin EV et al. Surgical treatment of patients with stages IB and IIA carcinoma of the cervix and palpable positive pelvic nodes. Gynecol Oncol 1995 57: 145 9.
9. Delgado G, Bundy B, Zaino R et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990 38: 352 7.
10. Kridelka FJ, Berg DO, Neuman M et al. Adjuvant small pelvic radiation for patients with high risk stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. Cancer 1999 86: 2059 65.
11. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group [RTOG] and the European Organization for Research and Treatment of Cancer [EORTC]. Int J Radiat Oncol Biol Phys 1995 31: 1341 6.
12. Tsai CS, Lai CH, Wang CC et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999 75: 328 33.
13. Ho CM, Chien TY, Huang SH et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 2004 93: 458 64.
14. Lai CH, Hong JH, Hsueh S et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: analysis of 891 cases. Cancer 1999 85: 1537 46.
15. Aoki Y, Sasaki M, Watanabe M et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol 2000 77: 305 9.
16. Einhorn N, Trope C, Ridderheim M et al. A systematic overview of radiation therapy effects in cervical cancer (cervix uteri). Acta Oncol 2003 42: 546 56.
17. Lai CH, Lin TS, Soong YK, Chen HF. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1989 35: 193 8.
18. Ampil FL, Caldito G, Unger JB. Cancer of the cervix with endometrial extension treated by radiotherapy: a retrospective case-control study. Eur J Gynecol Oncol 2003 24: 362 4.
19. Schorge JO, Molpus KL, Koelliker D et al. Stage IB. and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 1997 66: 31 5.
20. Delgado G, Bundy BN, Fowler WC Jr. et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989 35: 314 20.
21. Kim JH, Kim HJ, Hong S et al. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma. Gynecol Oncol 2005 96: 407 14.
22. Pieterse QD, Trimbos JB, Dijkman A et al. Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early stage cervical cancer: a retrospective comparative study. Int J Gynecol Cancer 2006 16: 1112 8.
23. Pieterse QD, Kenter GG, Gaarenstroom KN et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol doi: 10.1016/.ejso.2006.09.037.
24. Tinga DJ, Timmer PR, Bouma J, Aalders JG. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 1990 39: 175 80.
25. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990 65: 1923 7.
26. Brown JM, Lemmon MJ. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors. Cancer Res 1990 50: 7745 9.
27. Von Pawel J, von Roemeling R, Gatzemeier U et al. Tirapazamine plus cisplatin versus cisplatin in advanced non small cell lung cancer: a report of the International CATAPULT 1 Study Group. Cisplatin and tirapazamine in subjects with advanced previously untreated non small cell lung cancer tumors. J Clin Oncol 2000 18: 1351 9.
28. Bonner JA, Giralt J, Harari PM et al. Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of the head and neck: a phase III study of high dose radiotherapy with or without Cetuximab [abstract]. Proc Am Soc Clin Oncol 2004 23: 488. Abstract 5507.
29. Knecht R, Peters S, Adunka O et al. Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents. Anticancer Res 2003 23: 2577 83.
30. Sardi JE, Giaroli A, Sananes C et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage IB squamous carcinoma of the cervix. The final results. Gynecol Oncol 1997 67: 61 9.
31. Kumar L, Grover R, Pokharel YH et al. Neoadjuvant chemotherapy in locally advanced cervical cancer: two randomized studies. Aust N Z J Med 1998 28: 387 90.
32. Tattersall MHN, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer 1992 2: 244 51.
33. Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials. Eur J Cancer 2003 39: 2470 86.
34. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999 340: 1154 61.
35. Whitney CW, Sause W, Bundy BN et al. A randomized comparison of fluoroucil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group. J Clin Oncol 1999 17: 1339 48.
36. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based chemoradiation in locally advanced cervical cancer. N Engl J Med 1999 340: 1144 53.
37. Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial [RTOG] 90-01. J Clin Oncol 2004 22: 872 80.
38. Peters WA III., Liu PY, Barrett RJ et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000 18: 1606 13.
39. Pearcey R, Brundage M, Drouin P et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002 20: 966 72.
40. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomittant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001 358: 781 6.
41. National Cancer Institute. NCI clinical announcement. Bethesda, MD: United States Department of Health and Human Sources, Public Health Service, National Institutes of Health, 1999.